Daily Clip
여드름 치료제 시장, 애크논 '독주' 2위와 두 배 격차
2026.02.20
<!doctype html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width,initial-scale=1"><meta name="x-apple-disable-message-reformatting"><!--[if !mso]><!--><meta http-equiv="X-UA-Compatible" content="IE=edge"><!--<![endif]--><title></title><!--[if mso]> <style type="text/css"> table { border-collapse: collapse; border: 0; border-spacing: 0; margin: 0; } div, td { padding: 0; } div { margin: 0 !important; } ul, li { margin: 0; } </style> <noscript> <xml> <o:OfficeDocumentSettings> <o:AllowPNG/> <o:PixelsPerInch>96</o:PixelsPerInch> </o:OfficeDocumentSettings> </xml> </noscript> <![endif]--><style>@media screen and (max-width: 460px) { .stb-two-col .stb-column { max-width: 100% !important; } } @media screen and (min-width: 461px) { .stb-two-col .stb-column { max-width: 50% !important; } } @media screen and (max-width: 640px) { img.stb-justify { width: 100% !important; } } .stb-one-col p, .stb-two-col p { margin: 0px !important; }</style></head><body class="$stb-htmlv3$"><div role="article" aria-roledescription="email" style="-webkit-text-size-adjust: 100%;-ms-text-size-adjust: 100%;padding: 20px 0px;margin: 0 auto;"><div style="height:0px;max-height:0px;border-width:0px;border: 0px;border-color:initial;border-image:initial;visibility:hidden;line-height:0px;font-size:0px;overflow:hidden;display:none;"></div><table id="$beacon$"><tbody><tr><td></td></tr></tbody></table><table id="stb-container" role="presentation" style="width:100%;" border="0" bordercolor=""><tbody><tr><td align="center"><!--[if mso]> <table role="presentation" align="center" style="width:630px;background:#ffffff;"> <tr> <td> <div class="outer"> <![endif]--><!--[if !mso]><!--><div class="outer" style="width:100%;max-width:630px;background:#ffffff;margin: 0px auto;"><!--<![endif]--><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box" style="padding:0 0;text-align:left;margin:0px;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%" class="stb-permalink"><tbody><tr><td style="padding:15px 15px 0px 15px;"><div><span style="font-weight: bold; font-style: italic;" class="stb-bold stb-italic">2026-02-20</span></div></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:0px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:center;font-size:0;box-sizing:border-box;"><a href="https://www.brpinsight.com/" target="_blank" style="text-decoration: none; color: #0000ff;"><img src="https://img2.stibee.com/440332_2907895_1753165422184361025.png" alt="" style="width:476px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="476" class="stb-center"></a></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:0px 15px 0px 15px;"><div style="text-align: center;"><h2 class="main-visual--title" style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-size: 16px;">제약 산업의 주요 뉴스를 고르고, </span><span style="font-size: 16px;">데이터를 더해 뉴스레터를 발행합니다. </span></h2></div></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#1b1b1b;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><h1 class="heading" style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-size: 16px; color: #ffffff;" class="stb-fore-colored">여드름 치료제 시장, 애크논 '독주' 2위와 두 배 격차</span><span class="stb-fore-colored" style="color: #ffffff; font-size: 16px;"><a href="https://www.kpanews.co.kr/news/articleView.html?idxno=529695" class="stb-fore-colored" style="color: #ffffff; text-decoration: none;" target="_blank">🔗</a></span></h1></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><div data-message-author-role="assistant" data-message-id="5f499d48-bf40-47f4-9ef3-3951cc8d4679" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="2150328f-794d-4628-9524-69c0f5bc1210" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="5e96962a-0360-42f7-8b07-6de2981bd07a" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="0f2a594a-84a2-44c2-89b7-0952819d7c8e" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="bc2e13e8-0c10-432a-9a72-de346157d2bc" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="e37130fc-67a4-4b82-a681-e5dd639833d8" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="ecbe729a-f673-49c7-aebe-18f9e4967e4d" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="e93eea5d-01d2-4c41-8e40-0b2c9d5ede6a" data-message-model-slug="gpt-5-1"><div><div>2025년 여드름 치료제 시장은 애크논이 2위와 두배 가까운 매출 차이가 발생하며 독주한 것으로 확인됐다.</div><div>BRP인사이트에 따르면 2025년 ‘여드름 치료제’ 시장 총 매출액은 약 1277억원으로 확인됐다.</div><div>월별 흐름을 보면 2025년 1월부터 3월까지 60억원 이상의 높은 매출로 정점을 찍은 후 이후 45억원에서 55억원 사이의 안정적인 박스권을 형성했다.</div><div>여드름 치료제 시장은 총 50개 브랜드와 12개 주요 활성 성분이 경쟁했다. 이 중 특히 눈에 띄는 것은 일반의약품으로 소비자들에게 친숙한 제품들이 시장을 주도하고 있는 것으로 나타났다.</div><div>특히 동아제약 ‘애크논’의 경우 16억3800만원으로, 8억원대 매출로 2위를 차지한 레오파마 ‘아젤리아’에 두 배 이상 격차를 보이며 1위에 오른 것으로 확인됐다.</div></div><div><span style="font-size: 14px;">[약사공론l 26.02.20]</span></div></div></div></div></div></div></div></div></div></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_3245511_1771567442331843473.jpg" alt="" style="width:250px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="250" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table role="presentation" class="stb-one-col" style="width: 100%;background:#ffffff;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#000000;mso-padding-alt:0px;border-radius:3px;border:2px solid ;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/16443/products/25637" style="font-size:14px;display:inline-block;color:#000000;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank"><b>BRPInsight 트렌드 - 여드름 치료제 시장에서 독주 중인 '애크논'이 궁금하다면? [클릭]</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><h1 class="heading" style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-size: 16px; color: #ffffff;" class="stb-fore-colored">제약바이오 시가총액 TOP 20 재편…4위부터 순위 변동 활발</span><span class="stb-fore-colored" style="color: #ffffff; font-size: 16px;"><a href="https://www.medipana.com/news/articleView.html?idxno=407061" class="stb-fore-colored" style="color: #ffffff; text-decoration: none;" target="_blank">🔗</a></span></h1></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><div data-message-author-role="assistant" data-message-id="cd67ce81-d697-4c86-af2b-0e6ecb4b034d" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="4e0bc9db-1fcc-4a32-b01f-937ecf68b908" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="7a9f1044-5059-42cf-8115-0f5d0134c67e" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="5a442fb9-6ff3-42b2-a62c-ab348b9dedd6" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="0236dd20-5a61-4be2-854c-29995758093e" data-message-model-slug="gpt-5-1"><div data-message-author-role="assistant" data-message-id="1018cd14-34ed-4cd3-80f4-d4e13b08b4dd" data-message-model-slug="gpt-5-1"><div><div>지난 1년간 코스피·코스닥 제약바이오 기업 시가총액 순위에 변동이 나타났다. 1위부터 3위까진 자리를 지켰으나, 4위부턴 시가총액이 2배 이상 증가하면서 시총 순위 상승을 도모한 업체가 확인됐다.</div><div>19일 거래소에 따르면, 같은 날 코스피(KOSPI)·코스닥(KOSDAQ) 지수는 5677.25, 1160.71로 전 거래일 대비 3.09%, 4.94% 상승했다. 코스피 지수는 사상 처음으로 5600선을 돌파했으며, 코스닥 지수는 역대 최고 수준을 이어가고 있다.</div><div>이에 맞춰 메디파나뉴스는 코스피·코스닥에 상장한 제약바이오 업체 시가총액 상위 20곳 순위 변화를 살펴봤다.</div><div>1년 전 시총 순위에서 1위부터 3위까지 이름을 올린 삼성바이오로직스, 셀트리온, 알테오젠은 이날 시총 순위에서 기존 자리를 유지했다.</div><div>삼성바이오로직스는 이날 시총이 79조6204억원으로 전년 동일 82조2771억원 대비 3.23% 줄었으나 1위를 지켰다. 셀트리온과 알테오젠 시총은 1년 전 20조6344억원, 38조6679억원에서 이날 22조176억원, 56조4913억원으로 6.7%, 46.09% 늘었다.</div><div><div>시총 순위 변화는 4위부터 나타났다. 특히 시총이 전년 동일 이후 1년간 100% 이상 증가한 업체 9곳은 모두 시총 순위가 상승했다. 반면, 같은 기간 시총 증가율이 100%를 넘지 못한 기업은 셀트리온과 알테오젠을 제외하고 모두 시총 순위가 하락했다.</div></div></div><div><span style="font-size: 14px;">[메디파나| 26.02.20]</span></div></div></div></div></div></div></div></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_3245511_1771567778309807747.png" alt="" style="width:250px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="250" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table role="presentation" class="stb-one-col" style="width: 100%;background:#ffffff;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#1b1b1b;mso-padding-alt:0px;border-radius:3px;border:2px solid ;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/distributor/97" style="font-size:14px;display:inline-block;color:#1b1b1b;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank"><b>BRPInsight 트렌드 - 시가총액이 200% 이상 늘어나며 4위를 차지한 '삼천당제약'에 대해 알고 싶다면?</b><b> [클릭] </b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><h2 class="news_title" style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-size: 16px; color: #ffffff;" class="stb-fore-colored">하나제약 트라미펜세미정 등 트라마돌 제제 회수 지속</span><span style="color: #ffffff; font-size: 16px;" class="stb-fore-colored"><a href="https://dailypharm.com/user/news/335844" class="stb-fore-colored" style="color: #ffffff; text-decoration: none;" target="_blank">🔗</a></span></h2></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><div data-message-author-role="user" data-message-id="2ca152de-dab1-4cb8-9d8b-dd1b24a4ea52"><div data-multiline=""><div data-message-author-role="user" data-message-id="a934d992-297f-4907-97a5-54d4592afd0d"><div data-multiline=""><div data-message-author-role="assistant" data-message-id="aa208759-725d-4dd0-9f91-c809bb2b666c" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="0a6a0bc8-47e1-4cdf-b637-534904df2836" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="dec45683-20a5-4745-b7e4-22e6b428f5f1" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="147fb3bd-4c37-4329-88e0-692e2edaae70" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="51bd4588-6483-425d-97e8-045420260816" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="0495df1b-a6bc-49bf-8161-c520d2389155" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="b39037c6-8302-47f2-a8d3-079f6e9779f0" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="57abece4-dd3d-418c-8f5d-e1c9966de5f6" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="d03da268-23c0-42d8-8e43-e4adf0d3bb17" data-message-model-slug="gpt-5"><div data-message-author-role="assistant" data-message-id="9cf34ce9-2eea-4794-87ff-4c226d29f356" data-message-model-slug="gpt-5-1"><div><div><p>트라마돌염산염 성분 의약품에서 불순물 초과 검출에 따른 회수가 이어지고 있다.</p><p>식품의약품안전처는 지난 13일 하나제약 '트라미펜세미정' 일부 제조번호 제품에 대한 회수명령을 내렸다고 밝혔다.</p><p>불순물(N-nitroso-desmethyl-tramadol) 허용기준 초과 검출에 따른 영업자 회수이다.</p><p>트라미펜세미정은 아세트아미노펜과 트라마돌염산염 성분이 결합된 복합제로, 중등도-중증의 급·만성 통증에 사용된다. 회수 제조번호는 3024(2026.10.19), 3028(2026.12.05)이다.</p><p>트라미펜세미정의 2024년도 생산실적은 17억원 가량이다.</p><p>같은날 식약처는 트라미펜세미정과 동일성분인 킵스바이오파마의 트라임정에 대해서 회수명령을 내렸다. 이 약 역시 니트로사민류 불순물 초과가 회수 원인이다.</p></div><span></span></div><span style="font-size: 14px;">[데일리팜l 26.02.20] </span></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_3245511_1771568286520141467.png" alt="" style="width:auto;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="276" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:5px 15px 5px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#1b1b1b;mso-padding-alt:0px;border-radius:3px;border:2px solid ;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/13580" style="font-size:14px;display:inline-block;color:#1b1b1b;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank"><b>BRPInsight 트렌드 - 불순물 초과 검출에 따른 회수 '트라미펜세미정'은? [클릭]</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#ffffff;mso-padding-alt:0px;background:#000000;border-radius:500px;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/" style="font-size:14px;display:inline-block;color:#ffffff;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank"><b>29,000여개 제품 트렌드 확인 하러가기 🏃♀️➡️</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;background:#000000;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:justify;font-size:0;box-sizing:border-box;padding:0px 0px 15px 0px;"><img src="https://img2.stibee.com/440332_2904285_1752761435069828722.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:justify;max-width:100% !important;height:auto;border:0;" width="630" class="stb-justify"></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:15px 15px 15px 15px;"><a href="https://www.brpinsight.com/signup" target="_blank" style="text-decoration: none; color: #0000ff;"><img src="https://img2.stibee.com/440332_3048206_1760946292445398097.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="600" class="stb-center"></a></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box stb-permalink stb-footer" style="text-align:center;margin:0px;;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;border:0;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="padding:15px 15px 15px 15px;text-align:center;"><div><span>BRPInsight</span><br><span>brpnews@brpinsight.com</span><br><span class="stb-fore-colored">(주)BRP커넥트 | 서울 강남구 역삼로 169 명우빌딩 | </span><br><a href="https://stibee.com/error/preview" class="stb-underline stb-marked" target="_blank" rel="noopener" style="color: #747579;">수신거부</a><span> </span><a href="https://stibee.com/error/preview" class="stb-underline stb-marked" target="_blank" rel="noopener" style="color: #747579;">Unsubscribe</a></div></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table></div><!--[if mso]> </td> </tr> </table> <![endif]--></td></tr></tbody></table><div style="padding: 10pt 0cm 10pt 0cm;"><p class="MsoNormal" align="center" style="text-align: center;"><span lang="EN-US"></span></p></div></div></body></html>